Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration
Author:
- Age-Related Eye Disease Study 2 Research GroupAGAge-Related Eye Disease Study 2 Research Group
Top Cited Papers
Open Access
- 15 May 2013
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 309 (19) , 2005-2015
Abstract
Age-related macular degeneration (AMD), the leading cause of blindness in the developed world, accounts for more than 50% of all blindness in the United States.1 In 2004, it was estimated that 8 million individuals had intermediate AMD, defined as bilateral drusen, and approximately 2 million had advanced AMD, either neovascular AMD or geographic atrophy.2 Although intraocular drugs that inhibit vascular endothelial growth factor are currently available for treatment of neovascular AMD,3 no effective therapies are proven for atrophic AMD. Without more effective ways of slowing progression, the number of persons with advanced AMD is expected to double over the next 20 years, resulting in increasing socioeconomic burden.2Keywords
This publication has 19 references indexed in Scilit:
- Oral Docosahexaenoic Acid in the Prevention of Exudative Age-Related Macular DegenerationOphthalmology, 2013
- Secondary Outcomes in a Clinical Trial of Carotenoids with Coantioxidants versus Placebo in Early Age-related Macular DegenerationOphthalmology, 2013
- Fish Oil and Postoperative Atrial FibrillationJAMA, 2012
- Effect of Lutein and Zeaxanthin on Macular Pigment and Visual Function in Patients with Early Age-related Macular DegenerationOphthalmology, 2012
- The Age-related Eye Disease Study 2 (AREDS2)Ophthalmology, 2012
- Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degenerationOptometry - Journal of the American Optometric Association, 2011
- OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial InfarctionCirculation, 2010
- Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-caroteneEuropean Journal of Nutrition, 2010
- Faculty Opinions recommendation of Elevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quail.2002
- CAROTENOID BIOAVAILABILITY AND BIOCONVERSIONAnnual Review of Nutrition, 2002